salicylamide has been researched along with dinoprost in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (33.33) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Burke, MD; Falzon, M; Milton, AS | 1 |
| Akiyama, K; Mita, H; Ono, E; Taniguchi, M | 1 |
1 trial(s) available for salicylamide and dinoprost
| Article | Year |
|---|---|
Salicylamide-induced anaphylaxis: increased urinary leukotriene E4 and prostaglandin D2 metabolite.
Topics: Adolescent; Anaphylaxis; Anti-Inflammatory Agents, Non-Steroidal; Dinoprost; Drug Hypersensitivity; Female; Humans; Leukotriene E4; Prostaglandin D2; Salicylamides | 2008 |
2 other study(ies) available for salicylamide and dinoprost
| Article | Year |
|---|---|
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Are the decreases in hepatic cytochrome P-450 and other drug-metabolising enzymes caused by indomethacin in vivo mediated by intestinal bacterial endotoxins? 16,16-Dimethylprostaglandin F2 alpha prevents decreases in hepatic drug-metabolising enzymes due
Topics: Animals; Anti-Bacterial Agents; Cytochrome P-450 Enzyme System; Dinoprost; Electrophoresis, Polyacrylamide Gel; Endotoxins; Escherichia coli; In Vitro Techniques; Indomethacin; Intestines; Male; Microsomes, Liver; Mixed Function Oxygenases; Prostaglandins F, Synthetic; Rats; Rats, Inbred Strains; Salicylamides | 1984 |